Literature DB >> 8015282

Tumor cell invasion, matrix metalloproteinases, and the dogma.

L T Furcht, A P Skubitz, G B Fields.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8015282

Source DB:  PubMed          Journal:  Lab Invest        ISSN： 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  7 in total

1.  Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.

Authors:  P Liokumovich; I Goldberg; B Davidson; W H Gotlieb; T Zahavi; G Ben-Baruch; I Reder; J Kopolovic
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.

Authors:  S Peyrol; M Raccurt; F Gerard; C Gleyzal; J A Grimaud; P Sommer
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  NMR studies demonstrate a unique AAB composition and chain register for a heterotrimeric type IV collagen model peptide containing a natural interruption site.

Authors:  Jianxi Xiao; Xiuxia Sun; Balaraman Madhan; Barbara Brodsky; Jean Baum
Journal:  J Biol Chem       Date:  2015-07-24       Impact factor: 5.157

4.  Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.

Authors:  W C Duivenvoorden; H W Hirte; G Singh
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

5.  Alpha 6 beta 4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Continuous expression of laminins but not that of collagen VII is preserved in invasive parts of the carcinomas: implications for acquisition of the invading phenotype.

Authors:  T Tani; T Karttunen; T Kiviluoto; E Kivilaakso; R E Burgeson; P Sipponen; I Virtanen
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

6.  Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.

Authors:  P Ring; K Johansson; M Höyhtyä; K Rubin; G Lindmark
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo.

Authors:  S Kauppila; M K Bode; F Stenbäck; L Risteli; J Risteli
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.